The Effect of Different Doses of Ropivacaine for Caudal Block in School-aged Children Undergoing Shang Ring Circumcision

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300068603

Enrollment

Unknown

Registered

2023-02-24

Start date

2022-10-25

Completion date

Unknown

Last updated

2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

children undergoing circumcision

Interventions

P1 group:0.20% ropivacaine:0.20% ropivacaine

P2 group:0.25% ropivacaine:0.25% ropivacaine

P3 group:0.3% ropivacaine:0.3% ropivacaine

Eligibility

Sex/Gender

Male

Age

6 Years to 12 Years

Inclusion criteria

Inclusion criteria: ASA I-II, 6-12 years old and body mass index<35 kg.m2

Exclusion criteria

Exclusion criteria: abnormal coagulation function, allergy to local anesthetics, abnormal sacral anatomy, and puncture site infection Ambiguous sacral canal puncture and surgery altered.

Design outcomes

Primary

Measure	Time frame
anesthesia quality,;	—

Secondary

Measure	Time frame
perioperative adverse events;	—

Countries

China

Contacts

Public Contactzhang bin

Children's Hospital Affiliated to Shandong University

qletyymzk@sina.com+8618866115706

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026